Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22

Abstract

Several recent studies indicate that the majority of families with five or fewer cases of breast cancer and no cases of ovarian cancer are not due to BRCA1 or BRCA2. It has been proposed that a further breast cancer susceptibility gene that may account for some of these families is located on chromosome 8p12-p22. We have identified 31 site-specific breast cancer families that have a greater than 80% posterior probability of being due to genes other than BRCA1 or BRCA2. These families have been examined for linkage to 8p12-p22 using markers flanking the putative location of the gene. The overall multi-point LOD score is strongly negative across the whole 44 cM. The individual multi-point LOD score is negative in 23 families and only exceeds 0.5 in a single family (with a multi-point LOD score of 1.22). The maximum heterogeneity LOD score was 0.03 at marker D8S136 with estimated proportion linked (α) of 3% (95% CI 0–30%). These data do not lend support to the hypothesis that chromosome 8p12-p22 harbours a familial breast cancer susceptibility gene.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Claus EB, Risch N and Thompson WD. . 1991 Am. J. Hum. Genet. 48: 232–242.

  • Easton DF, Bishop DT, Ford D, Crockford GP and the breast cancer linkage consortium. . 1993 Am. J. Hum. Genet. 52: 678–701.

  • Ford D, Easton DF, Stratton MR, Narod SA, Golgar D, Devilee P, Bishop D, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck T, Tonin P, Neuhausen S, Barkadottir R, Eyfjord J, Lynch H, Ponder B, Gayther S, Birch J, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott R, Maugard C, Vasen H, Seitz S, Cannon-Albright L, Schofield A, Zelada-Hedman . and the breast cancer linkage consortium. 1998 Am. J. Hum. Genet. 62: 676–689.

  • Hakansson S, Johansson O, Johansson U, Sellberg G, Loman N, Gerdes AM and Holmberg E. . 1997 Am. J. Hum. Genet. 60: 1068–1078.

  • Imbert A, Chaffanet M, Essioux L, Noguchi T, Adelaide J, Kerangueven F, Le Paslier D, Bonaiti-Pellie C, Sobol H, Birnbaum D and Pebusque M. . 1996 Genomics 32: 29–38.

  • Kerangueven F, Essioux L, Dib A, Noguchi T, Allione F, Dib A, Noguchi T, Allione F, Geneix J, Longy M, Liderau, Eisinger F, Pebusque M, Jacquemier J, Bonaiti-Pellie C, Sobol H and Birnbaum D. . 1995 Oncogene 10: 1023–1026.

  • Kruglyak L, Daly MJ, Reeve-Daly MP and Lander ES. . 1996 Am. J. Hum. Genet. 58: 1347–1363.

  • Malone K, Dalin J, Thompson J, O'Brien C, Francisco L and Ostrander E. . 1998 JAMA 279: 922–929.

  • Miki Y, Swensen J, Shattuck Eidens D, Futreal PA, Harshman K, Tavtigian S, Lui Q, Chochran C, Bennett L, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow P, Norris F, Helvering L, Morrison P, Rosteck P, Lai M, Barrett J, Lewis C, Neuhausen S, Cannon-Allbright L, Goldgar D, Wiseman R, Kamb A and Skolnick M. . 1994 Science 266: 66–71.

  • O'Connell JR and Weeks DE. . 1995 Nat. Genet. 11: 402–408.

  • Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton D, Evans C, Deacon J and Stratton M. . 1999 J. Natl. Cancer Inst. 91: 943–949.

  • Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst F, Hageman S, Arts P, Ligtenberg M, Meijers-Heijboer H, Klijn J, Vasen H, Cornelisse C, Veer L, Bakker E, Ommen G and Devilee P. . 1997 Nat. Genet. 17: 341–345.

  • Rahman N and Stratton MR. . 1998 Ann. Rev. Genet. 32: 95–121.

  • Schubert E, Lee M, Mefford H, Argonza R, Morrow J, Hull J, Dann J. . 1997 Am. J. Hum. Genet. 60: 1031–1040.

  • Seitz S, Rohde K, Bender E, Nothangel A, Kolble K, Schlag P and Scherneck S. . 1997a Oncogene 14: 741–743.

  • Seitz S, Rohde K, Bender E, Nothangel A, Pidde H, Ullrich O-M, El-Zehairy A, Haensch W, Jandrig B, Koble K, Schlag PM and Scherneck S. . 1997b Br. J. Cancer 76: 983–991.

  • Serova O, Mazoyer S, Puget N, Dubois V, Tonin P, Schugart Y, Goldgar D, Narod S, Lynch H and Lenoir G. . 1997 Am. J. Hum. Genet. 60: 486–495.

  • Spurr NK, Blanton S, Bookstein R, Clarke R, Cottingham R, Daiger S, Drayna D, Faber P, Horrigan S, Kas K, Kirchgessner C, Kumar S, Leach R, Luedecke H, Sim E, Sullivan L, Takle L, Vance J, Wagner M, Wells D, Westbrook C, Yaremko L, Zaletayev D, Zuffardi and Wood S. . 1995 Cytogenet. Cell Genet. 68: 148–155.

  • Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficence D, Kelsell D, Ford D, Tonin P, Bishop D, Spurr N, Ponder B, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkardottir R, Easton D, Bentley D, Futreal P, Ashworth A and Stratton MR. . 1995 Nature 378: 789–791.

  • Yaremko M, Recant W and Westbrook C. . 1995 Genes Chrom. Cancer 13: 186–191.

  • Yaremko M, Kutza C, Lyzak J, Mick R, Recant W and Westbrook C . 1996 Genes Chrom. Cancer 16: 189–195.

Download references

Acknowledgements

We are grateful to all the participating families. This research was supported by the Cancer Research Campaign, the Institute of Cancer Research, the Association for International Research (via grant MKHT 18 to D Goldgar) and the Medical Research Council (UK).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahman, N., Teare, M., Seal, S. et al. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22. Oncogene 19, 4170–4173 (2000). https://doi.org/10.1038/sj.onc.1203735

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203735

Keywords

This article is cited by

Search

Quick links